Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis
Ageing Research Reviews | Sep 18, 2017
Campbell JM, et al. - This study focused on metformin's geroprotective effect in humans. Data reported an association between metformin use and apparent reductions in all-cause mortality and diseases of ageing, indicating a possible geroprotective impact of metformin and its potential of extending life and healthspans.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries